<div class="blk_container">
    <p> 11.0% YoY growth in November, vs. 12.4% YoY in YTD10m17<br/><br/>
        Retail drug consumption continued to grow 11.0% YoY in November vs. 12.4%in YTD10m17and 11.5% in November 2016.
        On a quarterly basis, growth in3Q17was 14.6%, compared with 14.8%, 10.7%, 10.7%, 11.1% and 11.6% in2Q17, 1Q17,
        4Q16, 3Q16and 2Q16respectively. We remind investors that drugconsumption data have high correlation with
        hospital drug sales.<br/><br/>
        We remain constructive on the sector<br/><br/>
        We remain constructive on the healthcare sector in 2018on the back of improvingregulatory framework, foreseeable
        NRDL benefit and rebound of regulatoryapprovals of domestic names. We advise investors to focus on companies
        withnew product launches and existing products with limited pricing pressure suchas Sino Biopharm (1177.HK).</p>
</div>